Received Nov 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Late second dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 82-year-old female patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (received 1st dose on 30-JUN-2025, batch number:AZ2A3 and expiry date:05-FEB-2028). The patient did not receive the 2nd dose of Twinrix. The patient experienced incomplete course of vaccination (Verbatim: Late second dose). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date:03-NOV-2025 Registered pharmacist called about a late second dose/advise/guidelines on the patient´s vaccination schedule on patient that received a first dose back on June thirtieth twenty twenty-five. Vaccination date, vaccine detail and patient demographics were obtained in this call. No further information was obtained in this call. The Vaccine Administration Facility was the same as Primary Reporter.